Emcure Pharmaceuticals IPO: Growth Plans, Existing Profit & More | All You Need To Know

Namita Thapar, Whole Time Director, Emcure Pharmaceuticals along with Satish Mehta, MD & CEO, Emcure Pharmaceuticals gives insights on Emcure's IPO Issue opening on July 3 and explains why their profits went down in FY24.
#emcurepharma #pharma #ndtvprofit
For more videos subscribe to our channel: / @ndtvprofitindia
Visit NDTV Profit for more news: www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit.com/research-r...
Follow NDTV Profit here
Twitter: / ndtvprofitindia , / ndtvprofit
LinkedIn: / ndtvprofit
Instagram: / ndtvprofit
Facebook: / ndtvprofit

[@yashwanthr361]

Craaaaaaaaazy questions !!

[@AkashYadavOriginal]

Self proclaimed Phar"Maa" barely understands her own company. I'm out!

[@DEVDHARKNOWLEDGE]

She didn't take technical questions. 😂😂.

[@panwardeepak79]

😎👌

[@SGworldview]

Namita ki toh halat kharab lagri hai

[@girijanandankhuntia1464]

Its not a good one